Skip to main navigation
Header | Myriad Genetics
Myriad Logo
  • Investor Relations
  • Financial Reporting
    • Filings and Reports
      • SEC Filings
      • Quarterly & Annual Reports
      • Sustainability
    • Disclosures
      • GAAP to Non-GAAP Reconciliation
    • Resources
      • Investor FAQs
      • Email Alerts Subscription
  • Newsroom
  • About Myriad
    • Corporate information
      • Corporate Governance
      • Executive Team
      • Myriad Milestones
    • Latest events
      • Events & Presentations
      • Investor Day
  • Contact Us
NASDAQ:
MYGN
$4.75
3.49%
DAY HIGH

$4.83

YEAR HIGH

$8.74

DAY LOW

$4.44

YEAR LOW

$3.76

04/02/2026
    NASDAQ:
    MYGN
    $4.75
    3.49%
  • Investor Relations
  • Financial Reporting
    • Filings and Reports
      • SEC Filings
      • Quarterly & Annual Reports
      • Sustainability
    • Disclosures
      • GAAP to Non-GAAP Reconciliation
    • Resources
      • Investor FAQs
      • Email Alerts Subscription
  • Newsroom
  • About Myriad
    • Corporate information
      • Corporate Governance
      • Executive Team
      • Myriad Milestones
    • Latest events
      • Events & Presentations
      • Investor Day
  • Contact Us

Investor Relations

  • News Releases
    • All
    • Financial News
    • Corporate News
    • Product News
    • Pipeline News

Myriad Genetics to Release Fourth-Quarter Financial Results on Feb. 28, 2023

  • Read more about Myriad Genetics to Release Fourth-Quarter Financial Results on Feb. 28, 2023

Myriad Genetics to Participate in Upcoming Healthcare Conferences

  • Read more about Myriad Genetics to Participate in Upcoming Healthcare Conferences

Myriad Genetics to Present at 41st Annual J.P. Morgan Healthcare Conference

  • Read more about Myriad Genetics to Present at 41st Annual J.P. Morgan Healthcare Conference

Myriad Genetics Reports Third Quarter Financial Results

  • Read more about Myriad Genetics Reports Third Quarter Financial Results

Myriad Genetics to Release Third-Quarter Financial Results on Nov. 1, 2022

  • Read more about Myriad Genetics to Release Third-Quarter Financial Results on Nov. 1, 2022

Myriad Genetics Reports Second Quarter Financial Results

  • Read more about Myriad Genetics Reports Second Quarter Financial Results

Myriad Genetics to Release 2022 Second-Quarter Financial Results on Aug. 4, 2022

  • Read more about Myriad Genetics to Release 2022 Second-Quarter Financial Results on Aug. 4, 2022

Myriad Genetics to Share Update on Business Transformation, Research and Development Pipeline, and Growth Plans at Investor Day on Aug. 11, 2022

  • Read more about Myriad Genetics to Share Update on Business Transformation, Research and Development Pipeline, and Growth Plans at Investor Day on Aug. 11, 2022

Myriad Genetics Reports First Quarter Revenue and Reiterates Guidance for 2022

  • Read more about Myriad Genetics Reports First Quarter Revenue and Reiterates Guidance for 2022

Myriad Genetics to Release First-Quarter 2022 Financial Results on May 5, 2022

  • Read more about Myriad Genetics to Release First-Quarter 2022 Financial Results on May 5, 2022

Pagination

  • Previous page ‹‹
  • Page 5
  • Next page ››
Subscribe to Financial

Investor Relations Contact

Matt Scalo
801.584.3532
matt.scalo@myriad.com

Stock Quote

Stock Quote

Day High
Year High
Day Low
Year Low
Volume

Minimum 15 minutes delayed. Source: LSEG

Shareholder Tools

  • Email Alerts Subscription
  • Print
  • Share
  • RSS
  • Payers
  • Overview
  • Investors
  • Events + Presentations
  • News
  • Press Releases
  • Myriad Genetics Blog
  • Careers
  • Joining the Team
Myriad Genetics Logo
  • Terms of Use
  • Myriad Genetics, Inc. Privacy Policy
  • Language Assistance
  • Cookie Preferences
© 2022 Myriad Genetics, Inc.